Back to Search
Start Over
Studies on novel HIF activators, A-503451s
- Source :
- The Journal of Antibiotics. 69:754-758
- Publication Year :
- 2016
- Publisher :
- Springer Science and Business Media LLC, 2016.
-
Abstract
- In the course of our screening, we discovered a novel compound, A-503451A, as a potent hypoxia-inducible factor (HIF) activator. In human hepatocarcinoma HepG2 cells, A-503451A induced HIF-mediated luciferase reporter gene expression and stabilized HIF-1α protein. A-503451A increased the mRNA expression levels and the protein secretion of HIF-dependent genes, vascular endothelial growth factor and erythropoietin. Addition of excess ferric chloride to the culture medium suppressed the HIF-induction activity of A-503451A. A-503451A did not have iron-chelating activity in vitro, but decreased the intracellular labile iron pool concentration. These data indicate that A-503451A is a unique HIF activator.
- Subjects :
- Vascular Endothelial Growth Factor A
0301 basic medicine
Indoles
Biology
Iron Chelating Agents
03 medical and health sciences
chemistry.chemical_compound
Genes, Reporter
Drug Discovery
Humans
RNA, Messenger
Erythropoietin
Pharmacology
Regulation of gene expression
Activator (genetics)
Hep G2 Cells
Hypoxia-Inducible Factor 1, alpha Subunit
Molecular biology
In vitro
Culture Media
Vascular endothelial growth factor
Vascular endothelial growth factor A
030104 developmental biology
Secretory protein
Gene Expression Regulation
Hypoxia-inducible factors
chemistry
Fermentation
Intracellular
Subjects
Details
- ISSN :
- 18811469 and 00218820
- Volume :
- 69
- Database :
- OpenAIRE
- Journal :
- The Journal of Antibiotics
- Accession number :
- edsair.doi.dedup.....86e35fdfeae85d03a9c1fb6fc8db4e4a
- Full Text :
- https://doi.org/10.1038/ja.2016.20